id4070.html
In development: Guidance, quality standards and advice
Wed, 19 Feb 2025 20:59:00 GMT
Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy [ID4070] Technology appraisal guidance TBC Tislelizumab in combination for untreated ...